Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

News

Stay up to date on the latest crypto trends with our expert, in-depth coverage.

banner
Recommended high-quality projects for major clients (Re-staking, January 24)
VIPRecommended high-quality projects for major clients (Re-staking, January 24)

Summary EigenLayer's TVL increased from $250 million to $1.7 billion in just one month. The re-staking sector is witnessing extraordinary growth. However, it is important to note that, in comparison to the overall volume of LSD, the re-staking sector still has considerable room for growth. For users primarily holding ETH, depositing ETH in LSD protocols like Lido and then re-staking the acquired stETH to earn another profit presents a more advantageous strategy over the long term. Additionally, apart from the anticipated EigenLayer airdrop, projects like AltLayer will also airdrop their tokens to EigenLayer re-stakers. This could result in profits significantly surpassing initial expectations.

Bitget·2024/01/26 10:32
Arbitrum ecosystem
VIPArbitrum ecosystem

Bitget·2024/01/03 06:00
Flash
22:21
South32’s quarterly manganese output in Australia more than triples
The world's largest manganese producer generated a total of 1.09 million wet metric tons of this steel additive from its Australian and South African operations in the quarter ending March, up from 476,000 wet metric tons in the same period last year. This output was below the Visible Alpha consensus expectation of 1.25 million wet metric tons.
22:17
The probability that the Federal Reserve will keep interest rates unchanged in April is 100%.
Jinse Finance reports that on April 22, according to CME "FedWatch": the probability of the Federal Reserve raising rates by 25 basis points in April is 0%, while the probability of keeping rates unchanged is 100%. The probability that the Federal Reserve will cut rates by a total of 25 basis points by June is 1.7%, and the probability of keeping rates unchanged is 98.3%.
22:09
According to its latest filing with the US Securities and Exchange Commission (SEC), neuro-regulation technology company Neuraxis Inc. expects net sales to reach approximately $1.6 million for the first quarter ending March 31, 2026.
This financial forecast reflects the company's business development trends in the field of neuroscience. As a medical technology enterprise focused on innovative neuroregulation solutions, Neuraxis continues to advance the field of pain management through its patented technology platform. The quarterly revenue guidance disclosed by the company provides investors with an important reference for evaluating its business performance. In the context of the rapidly developing medical technology industry, this data will help the market better understand the company's growth trajectory and commercialization process.
VIP news